Following receipt of product registration, TruScreen’s Serbian distributor, MPG d.o.o Beograd has ordered 6 TruScreen cervical cancer screening devices which will be shipped in July 2021. Serbia with a population of ~9 million has a target screening market of approximately 3 million women.
Dr. Ivan Imre, TruScreen’s Commercial Lead for Central and Eastern Europe (CEE), based in Prague, said “this is an exciting development to see our real time Truscreen cervical cancer screening device being approved by the Serbian health regulator for active marketing by our Serbian distributor”.
Juliet Hull, Chief Executive Officer, said “after being in Central and Eastern Europe since mid-2020, Ivan and the team have focused on identifying markets within the region to open the market for our Truscreen cervical cancer screening device. These activities were conducted within the COVID-19 environment. I am looking forward to further breakthrough in other markets within the CEE region.”
The TruScreen cervical cancer screening device has also recently achieved product registrations in Czech Republic, Slovakia and Poland.
TruScreen is continuing to work with its distributors in developing these markets. This effort is supported by our new Central European Advisory Board tasked with steering local market access plans, including reimbursement and cervical cancer screening projects.